« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 61, Issue 4
, Pages
1117-1122
, 15 March 2005
A phase II study of hyperfractionated accelerated radiotherapy (HART) after induction cisplatin (CDDP) and vinorelbine (VNR) for stage III non–small-cell lung cancer (NSCLC)
To access this article, please choose from the options below
PII: S0360-3016(04)02086-3
doi: 10.1016/j.ijrobp.2004.07.692
© 2005 Elsevier Inc. All rights reserved.
« Previous
Next »
International Journal of Radiation Oncology * Biology * Physics
Volume 61, Issue 4
, Pages
1117-1122
, 15 March 2005
